Insider Trading News

Arcellx CFO Michelle Gilson sells shares price $700,959

Following these transactions, Gilson holds 9,582 shares of Arcellx widespread inventory. The gross sales included broker-assisted transactions to cowl tax…

1 month ago

Arcellx’s chief medical officer sells shares price $581,315

Christopher Heery, the Chief Medical (TASE:PMCN) Officer of Arcellx, Inc. (NASDAQ:ACLX), a $3.74 billion market cap biotech firm at the…

1 month ago

Tesla CFO Vaibhav Taneja sells shares value $2.89 million

Tesla Inc.'s (NASDAQ:TSLA) Chief Monetary Officer Vaibhav Taneja lately offered a good portion of his firm inventory. In accordance with…

1 month ago

Tesla’s CFO Vaibhav Taneja sells $2.89m in inventory

Tesla, Inc. (NASDAQ:TSLA) Chief Monetary Officer Vaibhav Taneja has reported important inventory transactions, based on a latest SEC submitting. Taneja…

1 month ago

Janux Therapeutics CEO David Campbell sells $300,004 in inventory

Janux Therapeutics, Inc. (NASDAQ:JANX), a $2.69 billion market cap biotech firm, noticed its President and CEO David Alan Campbell lately…

1 month ago

Vir Biotechnology director Vicki L. Sato sells $137,219 in inventory

Vicki L. Sato, a director at Vir Biotechnology, Inc. (NASDAQ:VIR), has offered a portion of her holdings within the firm.…

1 month ago

Rubrik CTO Arvind sells $6.39m in inventory

Nithrakashyap Arvind (NS:ARVN), Chief Know-how Officer of Rubrik, Inc. (NASDAQ:RBRK), an organization presently valued at $11.92 billion and displaying spectacular…

1 month ago

Rubrik CFO sells shares price $112,680

In a current SEC submitting, Rubrik, Inc. (NASDAQ:RBRK), a cloud knowledge administration firm with a market capitalization of $11.92 billion,…

1 month ago

Rubrik’s chief income officer Brian McCarthy sells shares value $4.33 million

Brian Ok. McCarthy, the Chief Income Officer of Rubrik, Inc. (NASDAQ:RBRK), lately offered a good portion of his holdings within…

1 month ago

Denali Therapeutics director Steve Krognes sells $69,484 in inventory

Steve Krognes, a director at Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion market cap biotech firm with sturdy monetary well…

1 month ago